Cite
HARVARD Citation
Deng, R. et al. (2020). Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study. Leukemia & lymphoma. 61 (1), pp. 56-65. [Online].